The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.(b)(4).
|
A barostim system was implanted on (b)(6) 2023, and therapy was left at the sub-therapeutic level of 1ma.The patient was planned to be discharged after a 12 hour observation period, however, the patient was still inpatient on (b)(6) 2023.It was noted the patient had complained of surgical site pain, and oxycodone was administered.It was unknown why the patient was not given tylenol and discharged.The patient was still inpatient on (b)(6) 2023, and complained of pain.It was reported that oxycodone had been administered to the patient multiple times and the patient was somnolent.Pain medications were discontinued (b)(6) 2023 on the direction of the physician to discharge the patient.As of (b)(6) 2023, the patient was still inpatient and complaining of surgical site pain.Later that day, the patient reported to be dizzy and barostim therapy was turned off.It was noted that there were no notes in the patient's chart that they experienced pain or dizziness, but the patient stated they experienced pain starting at the pocket site going up to their neck.The managing physician was unable to determine the root cause of the dizziness.As of the evening of (b)(6) 2023, the patient stated the pain had subsided.The patient was discharged over the weekend of (b)(6) 2023.
|